An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Matthew J Dufort, Linda A DiMeglio, Jeffrey A Bluestone, S Alice Long, Brian N Bundy, Kevan C Herold, Stephen E Gitelman, Desmond Schatz, Carla J Greenbaum, Anette-Gabriele Ziegler, Diane K Wherrett, Eva Tsalikian, Jay S Skyler, William E Russell, Henry Rodriguez, Antoinette Moran, Wayne Moore, Jennifer B Marks, Peter S Linsley, Jeffrey P Krischer, Peter A Gottlieb
The New England journal of medicine 2019;381(7):603-613